New directions in antihypertensive drug therapy.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D006801:Humans; D008074:Lipoproteins / Q000097:blood; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects; D011983:Receptors, Purinergic / Q000187:drug effects; D012084:Renin-Angiotensin System / Q000187:drug effects; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D008074:Lipoproteins; D011942:Receptors, Adrenergic, alpha; D011983:Receptors, Purinergic; D014665:Vasodilator Agents